Your browser doesn't support javascript.
loading
The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.
Thompson, Corinne N; Le, Thi Phuong Tu; Anders, Katherine L; Nguyen, Trong Hieu; Lu, Lan Vi; Nguyen, Van Vinh Chau; Vu, Thuy Duong; Nguyen, Ngoc Minh Chau; Tran, Thi Hong Chau; Ha, Thanh Tuyen; Tran, Vu Thieu Nga; Pham, Van Minh; Tran, Do Hoang Nhu; Le, Thi Quynh Nhi; Saul, Allan; Martin, Laura B; Podda, Audino; Gerke, Christiane; Thwaites, Guy; Simmons, Cameron P; Baker, Stephen.
Afiliación
  • Thompson CN; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; London School of Hygiene and Tropical Medicine, London, UK.
  • Le TP; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Anders KL; School of Biological Sciences, Monash University, Victoria, Australia.
  • Nguyen TH; Hung Vuong Hospital, Ho Chi Minh City, Viet Nam.
  • Lu LV; The Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
  • Nguyen VV; The Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.
  • Vu TD; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Nguyen NM; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran TH; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Ha TT; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran VT; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Pham VM; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Tran do HN; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Le TQ; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam.
  • Saul A; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Martin LB; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Podda A; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Gerke C; Novartis Vaccines Institute for Global Health(2), A GSK Company, Siena, Italy.
  • Thwaites G; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK.
  • Simmons CP; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; Department of Microbiology and Immunology, University of Melbourne, Australia.
  • Baker S; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: sbaker
Vaccine ; 34(6): 783-90, 2016 Feb 03.
Article en En | MEDLINE | ID: mdl-26742945

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Shigella sonnei / Inmunoglobulina G / Inmunidad Materno-Adquirida / Anticuerpos Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Shigella sonnei / Inmunoglobulina G / Inmunidad Materno-Adquirida / Anticuerpos Antibacterianos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido